Why life sciences real estate is an emerging asset class in Singapore

Singapore is one of the few APAC markets with a full end-to-end life sciences value chain that comprises manufacturing, R&D, sales & logistics. To date, Singapore has cultivated life sciences growth through a network of vibrant and strategically located clusters. While life sciences properties have begun to stand out as a growing asset class for real estate investors, where are the opportunities and how do they fit into the landscape of commercial real estate? Tricia Song, CBRE Head of Research, Singapore and Southeast Asia tells us more. See omnystudio.com/listener for privacy information.